CureVac
Julia Deibert has extensive experience in quality management and research within the biomedical field. Currently serving as Quality Manager at CureVac AG since August 2016, Julia previously worked as a Doktorandin at Universität Tübingen from July 2011 to June 2016. Julia also completed a research internship at FCRM - Fondation Congolaise pour la Recherche Médicale in 2014, focusing on malaria research, diagnostics, and education. Julia holds a Diplom in Biology from the University of Tübingen, earned between 2005 and 2011.
CureVac
8 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.